Concepedia

Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation

Xiaowen Tang, Benigno C. Valdez, Yunju Ma, Qianqian Zhang, Changju Qu, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu,

Bone Marrow Transplantation · 2021 · 25 citations · 19 references

DOI

Concepts

References

19

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Tim R. Mosmann · Journal of Immunological Methods · 1983 · 55.6K citations

, , +14

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Rafael Bejar, Allegra M. Lord, Kristen E. Stevenson et al. · Blood · 2014 · 556 citations · Full text

, , +12

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

, , +17

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2005 · 311 citations

, , +16